MHNI Patient Selection Strategies Research Studies and Others Joel R Saper, MD, FACP,FAAN Founder/Director, Michigan Head Pain and Neurological Institute.
Ultrasound-Guided Shoulder Injections in the Treatment of Subacromial Bursitis
LMCC Review: Pediatric Neurology Asif Doja, MD, FRCP(C) April 3 rd, 2008.
Intrathecal Therapies: Local and National Trends and Complications NANS 2010 Nandan Lad, MD, PhD; Robert T. Arrigo, MS; Melanie Hayden,MD; Paul Kalanithi,
Rakesh Jain, USA
Management. First and most important question….. treat or don’t treat? →confirmed epilepsy? →trigger or provoking factors ? →bothersome? →Patients view.
April 9, 2011 Diagnostic Molecular Pathology Update Christopher D. Gocke, M.D. Associate Professor of Pathology & Oncology Johns Hopkins Medical Institutions.
Antipsychotic Review Jena L. Ivey, PharmD, BCPS, CPP.
STN 125011 Tositumomab Therapeutic Regimen (TTR) [tositumomab plus I-131 tositumomab] Oncologic Drugs Advisory Committee December 17, 2002.
Patient Selection What You Must Know 2010 NANS Joel R Saper, MD, FACP, FAAN Director/ Founder Michigan Head Pain & Neurological Institute Ann Arbor, Mi.
![STN 125011 Tositumomab Therapeutic Regimen (TTR) [tositumomab plus I-131 tositumomab] Oncologic Drugs Advisory Committee December 17, 2002.](https://static.fdocuments.in/doc/330x215/56649dc45503460f94ab6f7b/stn-125011-tositumomab-therapeutic-regimen-ttr-tositumomab-plus-i-131-tositumomab.jpg)
